CollPlant Biotechnologies Ltd
Nasdaq · Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Rehovot, Israel
CLGN chart
What traders are saying about $CLGN
Latest postsCollPlant Biotechnologies Ltd news
- META_TITLE_QUOTE
Yahoo Finance Singapore ·
- CollPlant Proposes Name Change to OptiPhi Computing After LightSolver Acquisition
The Globe and Mail ·
- CollPlant’s LightSolver Secures $1.8 Million Israeli Innovation Grant
TipRanks ·
- Israel approves funding for laser computing at CollPlant (Nasdaq: CLGN) subsidiary.
Stock Titan ·
- LightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)
Yahoo Finance ·
- A Nov. 24 meeting puts a new name before CollPlant (Nasdaq: CLGN) shareholders.
Stock Titan ·
- CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light
Yahoo Finance ·
- A new name goes to CollPlant (CLGN) shareholders on November 24 after its computing expansion.
Stock Titan ·
- LightSolver Secures Paid Collaboration with the Israel Ministry of Defense for the Development of Photonic Computing Technology
Yahoo Finance ·
- COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT
Yahoo Finance ·
- LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
Yahoo Finance ·
- COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Yahoo Finance ·
CollPlant Biotechnologies Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.4M | $515,000 | $11.0M | $299,000 |
| Net income | -$11.5M | -$16.6M | -$7.0M | -$16.9M |
| Diluted EPS | $-0.94 | $-1.45 | $-0.62 | $-1.53 |
| Total assets (year end) | $10.8M | $18.7M | $34.1M | $37.8M |
| Cash and equivalents (year end) | $5.6M | $11.9M | $26.7M | $29.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About CollPlant Biotechnologies Ltd
- Ticker
- CLGN (Nasdaq)
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- Rehovot, Israel
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1631487
- Former names
- CollPlant Biotechnologies Ltd., CollPlant Holdings Ltd.
Frequently asked questions
What exchange is CollPlant Biotechnologies Ltd listed on?
CollPlant Biotechnologies Ltd trades on the Nasdaq under the ticker symbol CLGN.
What industry is CollPlant Biotechnologies Ltd in?
CollPlant Biotechnologies Ltd is classified by the SEC under "Orthopedic, Prosthetic & Surgical Appliances & Supplies", part of the Healthcare sector on StockTweeting.
Where is CollPlant Biotechnologies Ltd headquartered?
CollPlant Biotechnologies Ltd's business address on file with the SEC is in Rehovot, Israel.
When does CollPlant Biotechnologies Ltd's fiscal year end?
CollPlant Biotechnologies Ltd's fiscal year ends on December 31.
How much revenue did CollPlant Biotechnologies Ltd report?
CollPlant Biotechnologies Ltd reported $2.4M in revenue for calendar year 2025, according to its SEC filings.